Quantcast
Home > Quotes > ECYT

Endocyte, Inc. (ECYT) Quote & Summary Data

ECYT 
$23.86
*  
0.01
0.04%
Get ECYT Alerts
*Delayed - data as of Dec. 13, 2018  -  Find a broker to begin trading ECYT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    ECYT Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
24
Today's High / Low
$ 23.895 / $ 23.84
Share Volume
1,264,943
50 Day Avg. Daily Volume
3,254,086
Previous Close
$ 23.85
52 Week High / Low
$ 23.94 / $ 2.81
Market Cap
1,958,849,452
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.68
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.13

Intraday Chart

Shares Traded

Share Volume:
1,264,943
50 Day Avg. Daily Volume:
3,254,086

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.68

Trading Range

The current last sale of $23.86 is 749.11% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 23.895 $ 23.94
 Low: $ 23.84 $ 2.81

ETFs with ECYT as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
3.82% Invesco DWA NASDAQ Momentum ETF (DWAQ) -18.60 (-16.29%)
3.14% Invesco DWA Healthcare Momentum ETF (PTH) -14.46 (-15.41%)
2.03% Invesco DWA SmallCap Momentum ETF (DWAS) -9.11 (-16.09%)
0.44% iShares Microcap ETF (IWC) -18.16 (-16.86%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. We use drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. Our agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen, or PSMA, in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.  ... More ...  


Risk Grade

Where does ECYT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 23.86
Open Date:
Dec. 13, 2018
Close Price:
$ 23.86
Close Date:
Dec. 13, 2018

Consensus Recommendation

Analyst Info